Seven Seed Grants Awarded Under India-UK Research Initiative For Affordable, Effective Cancer Treatments: Govt
The Department of Biotechnology (DBT) and Cancer Research UK (CRUK) signed a Memorandum of Understanding (MoU) for a Cancer Research Initiative, “Affordable Approaches to Cancer” in November 2018.
The broad aim of the research initiative is to support high quality research to deliver innovative and translatable outputs that accelerate progress against cancer outcomes in both the countries, and which also have the potential to have major global impact.
Under the initiative, the core challenges have been identified and seven seed grants have been awarded. The seven seed grants awarded are to work on affordable approaches to improve early diagnosis of symptomatic cancers, affordable screening tools to improve early detection of cancer, risk factors to better understand regional variations in incidence, enabling new approaches to cancer prevention, computational approaches that can reduce the cost of cancer care delivery, affordability of effective cancer treatments, affordable screening tools to improve early detection of cancer, and affordability of effective cancer treatments.
This information was given by Dr Harsh Vardhan, Union Minister for Science and Technology, Earth Sciences and Health and Family Welfare in a written reply in Lok Sabha on Friday (19 March).
The institutions involved from the Indian side include Cachar Cancer Hospital and Research Centre, RTI International, Translational Health Science Technology Institute, Tata Memorial Hospital, All India Institute for Medical Sciences, Cochin Cancer Research Centre, Chittaranjan National Cancer Institute.
The investment thus far by both the countries as a matching grant for supporting seven seed grants is Rs 1.86 crore.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.